| Filed | Description | |
|---|---|---|
| 2/20/26 | 1.01 Material Agreement | → |
| 1/14/26 | 1.01 Material Agreement | → |
| 11/17/25 | 1.01 Material Agreement | → |
| 10/24/25 | 1.011.02 Material Agreement · Agreement Terminated | → |
| 7/23/25 | 1.01 Material Agreement | → |
| 4/28/25 | 1.01 Material Agreement | → |
| ↓ 21 more | ||
, is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem.